Halpern Financial’s AstraZeneca AZN Stock Holding History

Halpern Financial’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$126K	Sell	794 -120	-13%	-$19.4K	0.03%	64
2024 Q2	$142K	Hold	914	–	–	0.04%	59
2024 Q1	$122K	Sell	914 -65	-7%	-$8.61K	0.04%	61
2023 Q4	$134K	Buy	979 +635	+185%	+$82.5K	0.04%	62
2023 Q3	$46.6K	Sell	344 -59	-15%	-$8.06K	0.02%	83
2023 Q2	$57.7K	Buy	403 +9	+2%	+$1.32K	0.02%	77
2023 Q1	$54.7K	Sell	394 -125	-24%	-$16.8K	0.02%	75
2022 Q4	$70.4K	Hold	519	–	–	0.03%	70
2022 Q3	$56.9K	Sell	519 -81	-14%	-$10.3K	0.02%	75
2022 Q2	$79.2K	Sell	600 -123	-17%	-$16.1K	0.03%	69
2022 Q1	$95.9K	Hold	723	–	–	0.04%	75
2021 Q4	$84.2K	Hold	723	–	–	0.04%	64
2021 Q3	$86.8K	Sell	723 -316	-30%	-$36.8K	0.04%	57
2021 Q2	$124K	Buy	1,039 +85	+9%	+$9.33K	0.06%	47
2021 Q1	$94.8K	Hold	954	–	–	0.05%	46
2020 Q4	$95.3K	Sell	954 -100	-9%	-$10.6K	0.05%	43
2020 Q3	$115K	Sell	1,054 -116	-10%	-$12.9K	0.07%	35
2020 Q2	$124K	Buy	+1,170	New	+$121K	0.08%	32

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Halpern Financial's AZN Position: Q3 2024 in Review

Halpern Financial reduced its AstraZeneca (AZN) stake by 13% in Q3 2024, selling an estimated $19.4K and leaving 794 shares worth $126K. The position accounts for 0.03% of the portfolio, ranked #64.

Halpern Financial first reported a position in AZN in Q2 2020 and has held it in 18 quarters since. The position peaked at $142K in Q2 2024. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

Halpern Financial held 794 shares of AstraZeneca worth $126K as of Q3 2024.
Halpern Financial sold 120 AstraZeneca shares in Q3 2024, an estimated $19.4K.
AstraZeneca made up 0.03% of Halpern Financial's portfolio in Q3 2024, its #64 holding.
Halpern Financial first reported a position in AstraZeneca in Q2 2020 and has held it in 18 quarters since.
Halpern Financial's AstraZeneca position peaked at $142K in Q2 2024.
1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on Halpern Financial's 13F filing for Q3 2024, filed 4 Oct 2024.